Absci Corp (ABSI)

$3.38 -0.17 (-4.79%)
Market Cap 505.39M
Revenue (ttm) 4.53M
Net Income (ttm) -103.11M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,276.16%
Debt to Equity Ratio 0.01
Volume 7,255,000
Avg Vol 5,513,052
Day's Range N/A - N/A
Shares Out 149.52M
Stochastic %K 74%
Beta 2.06
Analysts Strong Sell
Price Target $8.74

Company Profile

Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to design differentiated antibody therapeutics. Its preclinical development programs include ABS-101 for the treatment of inflammatory bowel disease; ABS-201 for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agree...

Industry: Biotechnology
Sector: Healthcare
Phone: 360 949 1041
Address:
18105 SE Mill Plain Boulevard, Vancouver, United States
Fooligan
Fooligan Oct. 6 at 5:00 AM
$ABSI Breaking out of downtrend channel into demand zone. looks like retest of channel is about to happen for an entry. Decent bullish flows. A lot of upside if it can hold the break out.
0 · Reply
highnihilism
highnihilism Oct. 5 at 4:59 PM
$ABSI Absci (option volume 10-03-25) 3.38 -4.8% | 320 trades | total $140.1K | 90-day avg $60.7K × 2.31 call $134.6K | put $5.5K | 97% single-leg, 2% multi-leg, 1% contingent
0 · Reply
musky54
musky54 Oct. 4 at 4:12 PM
$ABSI be nice if they drop that partnership news next week
1 · Reply
SweepCastApp
SweepCastApp Oct. 4 at 9:10 AM
$ABSI: Unusual Options Activity Alerted CALL flow observed 609x contracts at Strike price of $3 Exp on 02/20/2026 with Premium of $55K and showing BULLISH Sentiment
0 · Reply
crett
crett Oct. 3 at 6:05 PM
$ABSI average down. Lets go
0 · Reply
David185018
David185018 Oct. 3 at 1:23 PM
$ABSI Let’s go break through $3.76!
1 · Reply
YFZ450
YFZ450 Oct. 3 at 1:11 PM
$ABSI why is this moving up? I sold when cathie bought
1 · Reply
Winning_calls
Winning_calls Oct. 3 at 12:10 PM
$ABSI 👆👆👆
0 · Reply
healthcareguru
healthcareguru Oct. 3 at 11:47 AM
$CLPT $ABCL $ABSI $KMTS $QSI buying/holding a single share of these makes you dumber than a rock…you’ve been warned. All have >50% downside on tap fast. 👎🐺
3 · Reply
BullseyeStock
BullseyeStock Oct. 3 at 1:30 AM
GIPR is the type of setup market is loving right now. When more folks finds this, expecting big things! Float is very small on it, so will go up fast! Be early bulls, GIPR has the parabolic look! GIPR ✅Partnerships = increase revenues ✅Go private = They are undervalued currently compared to peers and revenues ✅Joint venture = would increase share price tremendously ✅Sale of the company = they would get probably 4x-5x minimum their yearly revenues. Watching: $GRNQ $AMZE $ARBK $ABSI
0 · Reply
Latest News on ABSI
Absci Boosts AI-Powered Drug Discovery With Oracle And AMD Collaboration

Sep 11, 2025, 12:10 PM EDT - 24 days ago

Absci Boosts AI-Powered Drug Discovery With Oracle And AMD Collaboration

AMD ORCL

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

Sep 11, 2025, 8:00 AM EDT - 24 days ago

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

Absci Corporation (ABSI) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 9, 2025, 12:13 AM EDT - 27 days ago

Absci Corporation (ABSI) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg

Aug 25, 2025, 4:05 PM EDT - 5 weeks ago

Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg

Absci to Participate in Upcoming Investor Conferences

Aug 20, 2025, 8:00 AM EDT - 6 weeks ago

Absci to Participate in Upcoming Investor Conferences

Absci Corporation (ABSI) Q2 2025 Earnings Call Transcript

Aug 13, 2025, 12:25 AM EDT - 7 weeks ago

Absci Corporation (ABSI) Q2 2025 Earnings Call Transcript

Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results

Aug 12, 2025, 4:05 PM EDT - 7 weeks ago

Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results

Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target

Aug 7, 2025, 2:00 AM EDT - 2 months ago

Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target

Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025

Jul 30, 2025, 4:05 PM EDT - 2 months ago

Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025

Intel, Absci, AST SpaceMobile And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Jul 25, 2025, 8:34 AM EDT - 2 months ago

Intel, Absci, AST SpaceMobile And Other Big Stocks Moving Lower In Friday's Pre-Market Session

ASTS INTC

Absci Announces Pricing of Public Offering of Common Stock

Jul 24, 2025, 8:45 PM EDT - 2 months ago

Absci Announces Pricing of Public Offering of Common Stock

Absci Announces Proposed Public Offering of Common Stock

Jul 24, 2025, 4:54 PM EDT - 2 months ago

Absci Announces Proposed Public Offering of Common Stock

Absci Appoints Biopharma Leader Mary Szela to Board of Directors

Jul 7, 2025, 8:00 AM EDT - 3 months ago

Absci Appoints Biopharma Leader Mary Szela to Board of Directors

Absci Corporation (ABSI) Q1 2025 Earnings Call Transcript

May 13, 2025, 10:45 PM EDT - 5 months ago

Absci Corporation (ABSI) Q1 2025 Earnings Call Transcript

Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results

May 13, 2025, 4:05 PM EDT - 5 months ago

Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results

Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease

May 13, 2025, 4:01 PM EDT - 5 months ago

Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease

Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025

Apr 14, 2025, 4:05 PM EDT - 6 months ago

Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025

Absci Corporation: A Potential Turnaround Play In Biotech Amid A Tumultuous Market

Apr 3, 2025, 3:15 PM EDT - 6 months ago

Absci Corporation: A Potential Turnaround Play In Biotech Amid A Tumultuous Market

Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Mar 19, 2025, 8:15 AM EDT - 7 months ago

Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

HQY TNXP

Absci Corporation (ABSI) Q4 2024 Earnings Call Transcript

Mar 18, 2025, 7:37 PM EDT - 7 months ago

Absci Corporation (ABSI) Q4 2024 Earnings Call Transcript

Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results

Mar 18, 2025, 4:05 PM EDT - 7 months ago

Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results

Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025

Mar 4, 2025, 4:05 PM EST - 7 months ago

Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Mar 4, 2025, 4:00 PM EST - 7 months ago

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Absci to Participate in the KeyBanc Capital Markets Healthcare Forum

Mar 4, 2025, 8:00 AM EST - 7 months ago

Absci to Participate in the KeyBanc Capital Markets Healthcare Forum

Absci to Participate in the TD Cowen 45th Annual Health Care Conference

Feb 18, 2025, 8:00 AM EST - 8 months ago

Absci to Participate in the TD Cowen 45th Annual Health Care Conference

Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside

Jan 22, 2025, 1:22 PM EST - 9 months ago

Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside

AMD

Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference

Jan 22, 2025, 8:00 AM EST - 9 months ago

Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference

Absci Looks Cheap And Positioned For Growth With AMD's AI Backing

Jan 13, 2025, 2:05 AM EST - 9 months ago

Absci Looks Cheap And Positioned For Growth With AMD's AI Backing

AMD

Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery

Jan 10, 2025, 7:30 AM EST - 9 months ago

Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery

Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery

Jan 8, 2025, 7:00 AM EST - 9 months ago

Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery

Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health

Jan 6, 2025, 8:00 AM EST - 9 months ago

Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health

Absci Corporation (ABSI) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 10:01 AM EST - 11 months ago

Absci Corporation (ABSI) Q3 2024 Earnings Call Transcript

Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results

Nov 12, 2024, 7:30 AM EST - 11 months ago

Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results

Absci to Host R&D Day on December 12, 2024

Nov 7, 2024, 8:00 AM EST - 11 months ago

Absci to Host R&D Day on December 12, 2024

Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024

Oct 15, 2024, 8:00 AM EDT - 1 year ago

Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024

Absci: AI-Driven Platform Could Establish Best-In-Class TL1A Drug Targeting Profile

Oct 3, 2024, 12:36 PM EDT - 1 year ago

Absci: AI-Driven Platform Could Establish Best-In-Class TL1A Drug Targeting Profile

Absci Corporation (ABSI) Q2 2024 Earnings Call Transcript

Aug 16, 2024, 11:50 PM EDT - 1 year ago

Absci Corporation (ABSI) Q2 2024 Earnings Call Transcript

Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results

Aug 14, 2024, 4:01 PM EDT - 1 year ago

Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results

Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI

Aug 12, 2024, 8:00 AM EDT - 1 year ago

Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI

Absci Corporation Leverages AI For Rapid Drug Discovery And Promising Partnerships

Jul 28, 2024, 1:24 AM EDT - 1 year ago

Absci Corporation Leverages AI For Rapid Drug Discovery And Promising Partnerships

Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024

Jul 10, 2024, 8:00 AM EDT - 1 year ago

Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024

Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

May 28, 2024, 8:00 AM EDT - 1 year ago

Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Absci Corporation (ABSI) Q1 2024 Earnings Call Transcript

May 14, 2024, 1:30 PM EDT - 1 year ago

Absci Corporation (ABSI) Q1 2024 Earnings Call Transcript

Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results

May 14, 2024, 7:30 AM EDT - 1 year ago

Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results

Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results

Mar 21, 2024, 7:30 AM EDT - 1 year ago

Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results

Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters' Option to Purchase Additional Shares

Mar 1, 2024, 4:01 PM EST - 1 year ago

Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters' Option to Purchase Additional Shares

Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI

Feb 21, 2024, 7:30 AM EST - 1 year ago

Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI

Absci Appoints Professor Sir Mene Pangalos to its Board of Directors

Jan 10, 2024, 7:30 AM EST - 1 year ago

Absci Appoints Professor Sir Mene Pangalos to its Board of Directors

Absci to Participate in the 26th Annual Needham Growth Conference

Jan 3, 2024, 8:00 AM EST - 1 year ago

Absci to Participate in the 26th Annual Needham Growth Conference

Absci to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Dec 28, 2023, 8:00 AM EST - 1 year ago

Absci to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Fooligan
Fooligan Oct. 6 at 5:00 AM
$ABSI Breaking out of downtrend channel into demand zone. looks like retest of channel is about to happen for an entry. Decent bullish flows. A lot of upside if it can hold the break out.
0 · Reply
highnihilism
highnihilism Oct. 5 at 4:59 PM
$ABSI Absci (option volume 10-03-25) 3.38 -4.8% | 320 trades | total $140.1K | 90-day avg $60.7K × 2.31 call $134.6K | put $5.5K | 97% single-leg, 2% multi-leg, 1% contingent
0 · Reply
musky54
musky54 Oct. 4 at 4:12 PM
$ABSI be nice if they drop that partnership news next week
1 · Reply
SweepCastApp
SweepCastApp Oct. 4 at 9:10 AM
$ABSI: Unusual Options Activity Alerted CALL flow observed 609x contracts at Strike price of $3 Exp on 02/20/2026 with Premium of $55K and showing BULLISH Sentiment
0 · Reply
crett
crett Oct. 3 at 6:05 PM
$ABSI average down. Lets go
0 · Reply
David185018
David185018 Oct. 3 at 1:23 PM
$ABSI Let’s go break through $3.76!
1 · Reply
YFZ450
YFZ450 Oct. 3 at 1:11 PM
$ABSI why is this moving up? I sold when cathie bought
1 · Reply
Winning_calls
Winning_calls Oct. 3 at 12:10 PM
$ABSI 👆👆👆
0 · Reply
healthcareguru
healthcareguru Oct. 3 at 11:47 AM
$CLPT $ABCL $ABSI $KMTS $QSI buying/holding a single share of these makes you dumber than a rock…you’ve been warned. All have >50% downside on tap fast. 👎🐺
3 · Reply
BullseyeStock
BullseyeStock Oct. 3 at 1:30 AM
GIPR is the type of setup market is loving right now. When more folks finds this, expecting big things! Float is very small on it, so will go up fast! Be early bulls, GIPR has the parabolic look! GIPR ✅Partnerships = increase revenues ✅Go private = They are undervalued currently compared to peers and revenues ✅Joint venture = would increase share price tremendously ✅Sale of the company = they would get probably 4x-5x minimum their yearly revenues. Watching: $GRNQ $AMZE $ARBK $ABSI
0 · Reply
musky54
musky54 Oct. 3 at 12:12 AM
$ABSI I would like to finally say goodbye to the 2ss
0 · Reply
MoonCowBoy
MoonCowBoy Oct. 2 at 10:54 PM
$CELH $UPXI $ABSI $KDK !!!
0 · Reply
Medough
Medough Oct. 2 at 10:20 PM
$ABSI you will leave money on the table if you sell at $10
0 · Reply
MAs_Crxss
MAs_Crxss Oct. 2 at 7:44 PM
$ABSI Hopefully ABS-101 looks good
1 · Reply
UncleTrump
UncleTrump Oct. 2 at 7:11 PM
$ABSI I hear the tutes are loading, is this a good buy?
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Oct. 2 at 6:21 PM
$ABSI
0 · Reply
healthcareguru
healthcareguru Oct. 2 at 5:43 PM
Short the insanely overvalued junk/hype…all begging to get cut in half (at least) $KMTS $HTFL $ABSI $CLPT $QSI 🐺👎
3 · Reply
healthcareguru
healthcareguru Oct. 2 at 5:42 PM
Short the insanely overvalued junk/hype…all begging to get cut in half (at least)! $ABCL $HTFL $ABSI $CLPT $QSI 🐺👎
2 · Reply
flam70
flam70 Oct. 2 at 5:22 PM
$ABSI does anyone know the jpm price target
0 · Reply
healthcareguru
healthcareguru Oct. 2 at 4:17 PM
$ABSI broke below VWAP…it’s a bleeder into the close. And then you still have cash incineration and a massive estimate whiff to take this turd back to the gutter. 👎🐺
0 · Reply
LeronLegend_Visionary
LeronLegend_Visionary Oct. 2 at 3:31 PM
$ABSI I actually saw Green for a few seconds for the 1st time in a year or so. It’s coming
0 · Reply
Vrodcarpediem
Vrodcarpediem Oct. 2 at 3:10 PM
$ABCL $ABSI $DNA $GRAL $QSI
0 · Reply